Shimose, S., Iwamoto, H., Tanaka, M., Niizeki, T., Shirono, T., Noda, Y., . . . Torimura, T. (2021). Alternating Lenvatinib and Trans-Arterial Therapy Prolongs Overall Survival in Patients with Inter-Mediate Stage HepatoCellular Carcinoma: A Propensity Score Matching Study. Cancers (Basel).
Style de citation ChicagoShimose, Shigeo, et al. "Alternating Lenvatinib and Trans-Arterial Therapy Prolongs Overall Survival in Patients With Inter-Mediate Stage HepatoCellular Carcinoma: A Propensity Score Matching Study." Cancers (Basel) 2021.
Style de citation MLAShimose, Shigeo, et al. "Alternating Lenvatinib and Trans-Arterial Therapy Prolongs Overall Survival in Patients With Inter-Mediate Stage HepatoCellular Carcinoma: A Propensity Score Matching Study." Cancers (Basel) 2021.